Conventional drug delivery is fraught with limitations. Targeted delivery is a hot button issue in modern medicine, with developers exploring many avenues for more precise treatments.
Engineered oncolytic bacteria have emerged as a promising therapeutic platform for precision cancer treatment, offering tumor-specific colonization, immune activation, and controllable therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results